{"DataElement":{"publicId":"3227240","version":"1","preferredName":"Glioma Feature Present Quantity Category","preferredDefinition":"Text term that describes the relative amount of a particular morphological feature present in the glioma.","longName":"3219653v1.0:3227235v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3219653","version":"1","preferredName":"Glioma Feature Present","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004_A prominent or identifiable aspect, region, or site of interest._Being or existing in a specified place or at the specified time.","longName":"3219651v1.0:2233878v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3219651","version":"1","preferredName":"Neuroglial Tumor Feature","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004:A prominent or identifiable aspect, region, or site of interest.","longName":"C3059:C73619","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A01B7A8A-6891-1EAA-E040-BB89AD434F8E","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A01B7A8A-689F-1EAA-E040-BB89AD434F8E","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of L.Dillon 4/2011 sw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3227235","version":"1","preferredName":"Glioma Feature Quantity Category","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004_A prominent or identifiable aspect, region, or site of interest._Quantity; how much there is of something that you can measure._Category; used informally to mean a class of things.","longName":"3227235v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"11","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Abundant","valueDescription":"Abundant","ValueMeaning":{"publicId":"3227236","version":"1","preferredName":"Abundant","longName":"3227236","preferredDefinition":"Present in greater than or equal to 50 percent of tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-9400-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0C3F27F-9419-358A-E040-BB89AD43602C","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA","dateModified":"2011-04-12","deletedIndicator":"No"},{"value":"Present","valueDescription":"Present","ValueMeaning":{"publicId":"3227237","version":"1","preferredName":"Present","longName":"3227237","preferredDefinition":"Greater than 5 percent and less than 50 percent of tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-9423-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0C3F27F-943B-358A-E040-BB89AD43602C","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA","dateModified":"2011-04-12","deletedIndicator":"No"},{"value":"Minimal","valueDescription":"Minimal","ValueMeaning":{"publicId":"3227238","version":"1","preferredName":"Minimal","longName":"3227238","preferredDefinition":"The smallest possible quantity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-9445-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"DWARZEL","dateModified":"2019-03-25","changeDescription":"Added concept code DW 03-25-2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0C3F27F-945E-358A-E040-BB89AD43602C","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA","dateModified":"2011-04-12","deletedIndicator":"No"},{"value":"Not Present","valueDescription":"Not detected","ValueMeaning":{"publicId":"3227239","version":"1","preferredName":"Not detected","longName":"3227239","preferredDefinition":"Not detected","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-9468-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0C3F27F-9481-358A-E040-BB89AD43602C","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA","dateModified":"2011-04-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3227234","version":"1","preferredName":"Neuroglial Tumor Feature Quantity Category","preferredDefinition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004:A prominent or identifiable aspect, region, or site of interest.:Quantity; how much there is of something that you can measure.:Category; used informally to mean a class of things.","longName":"C3059:C73619:C25256:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Quantity","conceptCode":"C25256","definition":"How much there is of something that you can measure; the total amount or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-93D8-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-93E9-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"WHITES","dateModified":"2011-04-18","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of L.Dillon 4/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Glioma Feature Quantity","type":"Preferred Question Text","description":"Glioma Feature Quantity","url":null,"context":"NCIP"},{"name":"Mini-gemistocytes","type":"Alternate Question Text","description":"Mini-gemistocytes","url":null,"context":"NCIP"},{"name":"Multi-nucleated/giant cells","type":"Alternate Question Text","description":"Multi-nucleated/giant cells","url":null,"context":"NCIP"},{"name":"Multiple serpentine pseudopalisading pattern","type":"Alternate Question Text","description":"Multiple serpentine pseudopalisading pattern","url":null,"context":"NCIP"},{"name":"Nodular growth pattern","type":"Alternate Question Text","description":"Nodular growth pattern","url":null,"context":"NCIP"},{"name":"Small cell astrocytes","type":"Alternate Question Text","description":"Small cell astrocytes","url":null,"context":"NCIP"},{"name":"Small cell component","type":"Alternate Question Text","description":"Small cell component","url":null,"context":"NCIP"},{"name":"Circumferential endothelial hyperplasia","type":"Alternate Question Text","description":"Circumferential endothelial hyperplasia","url":null,"context":"NCIP"},{"name":"Complex/glomeruloid","type":"Alternate Question Text","description":"Complex/glomeruloid","url":null,"context":"NCIP"},{"name":"Endothelial hypertrophy","type":"Alternate Question Text","description":"Endothelial hypertrophy","url":null,"context":"NCIP"},{"name":"Entrapped gray matter","type":"Alternate Question Text","description":"Entrapped gray matter","url":null,"context":"NCIP"},{"name":"Entrapped white matter","type":"Alternate Question Text","description":"Entrapped white matter","url":null,"context":"NCIP"},{"name":"Epithelial metaplasia","type":"Alternate Question Text","description":"Epithelial metaplasia","url":null,"context":"NCIP"},{"name":"Mesenchymal metaplasia","type":"Alternate Question Text","description":"Mesenchymal metaplasia","url":null,"context":"NCIP"},{"name":"Microcalcifications","type":"Alternate Question Text","description":"Microcalcifications","url":null,"context":"NCIP"},{"name":"Zonal necrosis","type":"Alternate Question Text","description":"Zonal necrosis","url":null,"context":"NCIP"},{"name":"Perineuronal satellitosis","type":"Alternate Question Text","description":"Perineuronal satellitosis","url":null,"context":"NCIP"},{"name":"Perinuclear halos","type":"Alternate Question Text","description":"Perinuclear halos","url":null,"context":"NCIP"},{"name":"Oligodendroglioma component","type":"Alternate Question Text","description":"Oligodendroglioma component","url":null,"context":"NCIP"},{"name":"Oligodendroglioma-like component with perinuclear cytoplasmic halos","type":"Alternate Question Text","description":"Oligodendroglioma-like component with perinuclear cytoplasmic halos","url":null,"context":"NCIP"},{"name":"Perivascular satellitosis","type":"Alternate Question Text","description":"Perivascular satellitosis","url":null,"context":"NCIP"},{"name":"Polymorphonuclear leukocytic infiltrates","type":"Alternate Question Text","description":"Polymorphonuclear leukocytic infiltrates","url":null,"context":"NCIP"},{"name":"Chicken-wire vasculature","type":"Alternate Question Text","description":"Chicken-wire vasculature","url":null,"context":"NCIP"},{"name":"Fibrillary Astrocytes","type":"Alternate Question Text","description":"Fibrillary Astrocytes","url":null,"context":"NCIP"},{"name":"Gemistocytes","type":"Alternate Question Text","description":"Gemistocytes","url":null,"context":"NCIP"},{"name":"Lymphocytic infiltrates","type":"Alternate Question Text","description":"Lymphocytic infiltrates","url":null,"context":"NCIP"},{"name":"Macrophage/histiocytic infiltrates","type":"Alternate Question Text","description":"Macrophage/histiocytic infiltrates","url":null,"context":"NCIP"},{"name":"Microcysts","type":"Alternate Question Text","description":"Microcysts","url":null,"context":"NCIP"},{"name":"Micro-mineralization","type":"Alternate Question Text","description":"Micro-mineralization","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-94D9-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of L.Dillon 4/2011 Modified definition - moved system-generated definition to alternate definition and replaced primary definition with human readable format approved by TCGA/J.Demchok  mc 8/12/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}